Accelerate drug discovery and optimize clinical trials with advanced AI and data analytics
We understand the complexity of drug development and regulatory requirements in pharma
Shortening time-to-market for new therapeutics
Improving patient recruitment and retention efficiency
Managing complex FDA, EMA, and ICH requirements
Harmonizing data across research, manufacturing, and logistics
Accelerate compound screening and target identification using machine learning
Key Capability: Accelerates compound screening and identification to move promising candidates forward
Key Capability: Improves clinical trial efficiency through better patient matching and protocol optimization
Optimize trial execution through intelligent patient matching and protocol optimization.
Streamline regulatory documentation and ensure compliance across global markets.
Key Capability: Streamlines regulatory documentation and compliance processes for faster market approvals
AI analysis of biobanks to identify novel patient cohorts and biomarkers for rare genetic disorders
Machine learning models discovering new therapeutic indications for existing compounds
Predictive analytics improving yield, reducing waste, and enhancing batch consistency
AI-driven demand prediction ensuring optimal inventory levels across global distribution networks
Partner with AGILOS to bring breakthrough drugs to market faster with AI-powered discovery and development.
Discuss Drug Development